Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Eosinophilia
ADR ID BADD_A01511
ADR Hierarchy
01      Blood and lymphatic system disorders
01.02      White blood cell disorders
01.02.04      Eosinophilic disorders
01.02.04.001      Eosinophilia
Description A disorder characterized by laboratory test results that indicate an increased number of eosinophils in the blood. [CTCAE] Abnormal increase of EOSINOPHILS in the blood, tissues or organs. [MeSH]
MedDRA Code 10014950
MeSH ID D004802
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Eosinophilia | Eosinophilia (excl pulmonary) | Eosinophilic granulocytosis | Hypereosinophilia | Eosinophilic infiltration | Eosinophilias | Eosinophilia, Tropical | Eosinophilias, Tropical | Tropical Eosinophilias | Tropical Eosinophilia
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01439Methysergide--
BADD_D01440Methysergide maleate--
BADD_D01449Metronidazole0.000144%
BADD_D01451Metyrosine--
BADD_D01455Micafungin--
BADD_D01470Minocycline0.001476%
BADD_D01471Minocycline anion--
BADD_D01472Minocycline hydrochloride--
BADD_D01476Mirtazapine0.000200%
BADD_D01484Modafinil--
BADD_D01490Mometasone0.000059%
BADD_D01495Monomethyl maleate--
BADD_D01496Montelukast0.000095%
BADD_D01501Moxifloxacin--
BADD_D01502Moxifloxacin hydrochloride--
BADD_D01506Muromonab-cd3--
BADD_D01515Nafcillin0.000122%
BADD_D01521Nalidixic acid--
BADD_D01533Naproxen--
BADD_D01534Naproxen sodium--
BADD_D01544Nedocromil--
BADD_D01557Nevirapine--
BADD_D01566Nifedipine--
BADD_D01567Nilotinib--
BADD_D01576Nitrofurantoin--
BADD_D01577Nitrofurantoin (macrocrystals)--
BADD_D01578Nitrofurantoin (monohydrate/macrocrystals)--
BADD_D01582Nizatidine--
BADD_D01587Norfloxacin--
BADD_D01588Nortriptyline--
The 10th Page    First    Pre   10 11 12 13 14    Next   Last    Total 16 Pages